Biotech · Private company
Gedeon Richter Ltd.
Track this companyFree. Adds Gedeon Richter Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials111 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- CariprazinePhase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Prolia®Phase 3 · Postmenopausal OsteoporosisClinicalTrials.gov · fetched Nov 12, 2026
- RGB-14-PPhase 3 · Postmenopausal OsteoporosisClinicalTrials.gov · fetched Nov 12, 2026
- RGH-706Phase 2 · Prader-Willi SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult ParticipantsPHASE1 · COMPLETED · started Feb 15, 2023ClinicalTrials.gov NCT05738850 · fetched Nov 12, 2026
- Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi SyndromePHASE2 · COMPLETED · started Sep 22, 2022ClinicalTrials.gov NCT05322096 · fetched Nov 12, 2026
- Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal OsteoporosisPHASE3 · COMPLETED · started Sep 21, 2021ClinicalTrials.gov NCT05087030 · fetched Nov 12, 2026
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaPHASE3 · RECRUITING · started Jun 6, 2019ClinicalTrials.gov NCT03817502 · fetched Nov 12, 2026
- Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive DisorderPHASE3 · COMPLETED · started Apr 29, 2013ClinicalTrials.gov NCT01838876 · fetched Nov 12, 2026
- Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)PHASE3 · COMPLETED · started Nov 15, 2012ClinicalTrials.gov NCT01715805 · fetched Nov 12, 2026
- Long-term Study of Cariprazine in Patients With SchizophreniaPHASE3 · COMPLETED · started May 31, 2010ClinicalTrials.gov NCT01104792 · fetched Nov 12, 2026
- Long-term Safety and Tolerability of Cariprazine for Bipolar I DisorderPHASE3 · COMPLETED · started Feb 28, 2010ClinicalTrials.gov NCT01059539 · fetched Nov 12, 2026
- Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive DisorderPHASE2 · COMPLETED · started Jun 30, 2009ClinicalTrials.gov NCT00854100 · fetched Nov 12, 2026
- A Study of Cariprazine in Patients With Chronic Stable SchizophreniaPHASE2 · COMPLETED · started May 31, 2009ClinicalTrials.gov NCT00839852 · fetched Nov 12, 2026
- Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of SchizophreniaPHASE2 · COMPLETED · started Jun 30, 2008ClinicalTrials.gov NCT00694707 · fetched Nov 12, 2026